414 related articles for article (PubMed ID: 26423196)
41. Protection against parenteral HIV-1 infection by homozygous deletion in the C-C chemokine receptor 5 gene.
Kupfer B; Kaiser R; Brackmann HH; Effenberger W; Rockstroh JK; Matz B; Schneweis KE
AIDS; 1999 Jun; 13(9):1025-8. PubMed ID: 10397531
[TBL] [Abstract][Full Text] [Related]
42. Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?
Laurichesse JJ; Taieb A; Capoulade-Metay C; Katlama C; Villes V; Drobacheff-Thiebaud MC; Raffi F; Chêne G; Theodorou I; Leport C;
HIV Med; 2010 Apr; 11(4):239-44. PubMed ID: 20050936
[TBL] [Abstract][Full Text] [Related]
43. TALENs-mediated homozygous CCR5Δ32 mutations endow CD4+ U87 cells with resistance against HIV‑1 infection.
Yu AQ; Ding Y; Lu ZY; Hao YZ; Teng ZP; Yan SR; Li DS; Zeng Y
Mol Med Rep; 2018 Jan; 17(1):243-249. PubMed ID: 29115572
[TBL] [Abstract][Full Text] [Related]
44. Identification and frequency of CCR5Δ32/Δ32 HIV-resistant cord blood units from Houston area hospitals.
Gonzalez G; Park S; Chen D; Armitage S; Shpall E; Behringer R
HIV Med; 2011 Sep; 12(8):481-6. PubMed ID: 21375684
[TBL] [Abstract][Full Text] [Related]
45. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection.
de Roda Husman AM; Blaak H; Brouwer M; Schuitemaker H
J Immunol; 1999 Oct; 163(8):4597-603. PubMed ID: 10510404
[TBL] [Abstract][Full Text] [Related]
46. Stromal cell-derived factor (SDF) 1-3'A polymorphism may play a role in resistance to HIV-1 infection in seronegative high-risk Thais.
Tiensiwakul P
Intervirology; 2004; 47(2):87-92. PubMed ID: 15192272
[TBL] [Abstract][Full Text] [Related]
47. Natural controlled HIV infection: preserved HIV-specific immunity despite undetectable replication competent virus.
Kloosterboer N; Groeneveld PH; Jansen CA; van der Vorst TJ; Koning F; Winkel CN; Duits AJ; Miedema F; van Baarle D; van Rij RP; Brinkman K; Schuitemaker H
Virology; 2005 Aug; 339(1):70-80. PubMed ID: 15987650
[TBL] [Abstract][Full Text] [Related]
48. A Possible Sterilizing Cure of HIV-1 Infection Without Stem Cell Transplantation.
Turk G; Seiger K; Lian X; Sun W; Parsons EM; Gao C; Rassadkina Y; Polo ML; Czernikier A; Ghiglione Y; Vellicce A; Varriale J; Lai J; Yuki Y; Martin M; Rhodes A; Lewin SR; Walker BD; Carrington M; Siliciano R; Siliciano J; Lichterfeld M; Laufer N; Yu XG
Ann Intern Med; 2022 Jan; 175(1):95-100. PubMed ID: 34781719
[TBL] [Abstract][Full Text] [Related]
49. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro.
Wu L; Paxton WA; Kassam N; Ruffing N; Rottman JB; Sullivan N; Choe H; Sodroski J; Newman W; Koup RA; Mackay CR
J Exp Med; 1997 May; 185(9):1681-91. PubMed ID: 9151905
[TBL] [Abstract][Full Text] [Related]
50. Knowledge From London and Berlin: Finding Threads to a Functional HIV Cure.
Ding J; Liu Y; Lai Y
Front Immunol; 2021; 12():688747. PubMed ID: 34122453
[TBL] [Abstract][Full Text] [Related]
51. CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape.
Hütter G; Bodor J; Ledger S; Boyd M; Millington M; Tsie M; Symonds G
Viruses; 2015 Jul; 7(8):4186-203. PubMed ID: 26225991
[TBL] [Abstract][Full Text] [Related]
52. Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists.
Soulié C; Fourati S; Lambert-Niclot S; Malet I; Wirden M; Tubiana R; Valantin MA; Katlama C; Calvez V; Marcelin AG
J Antimicrob Chemother; 2010 Apr; 65(4):749-51. PubMed ID: 20150182
[TBL] [Abstract][Full Text] [Related]
53. Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection.
Marmor M; Sheppard HW; Donnell D; Bozeman S; Celum C; Buchbinder S; Koblin B; Seage GR;
J Acquir Immune Defic Syndr; 2001 Aug; 27(5):472-81. PubMed ID: 11511825
[TBL] [Abstract][Full Text] [Related]
54. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
[TBL] [Abstract][Full Text] [Related]
55. Analysis of the Spanish CCR5-∆32 inventory of cord blood units: lower cell counts in homozygous donors.
Enrich E; Vidal F; Sánchez-Gordo F; Gómez-Zumaquero JM; Balas A; Rudilla F; Barea L; Castro A; Larrea L; Perez-Vaquero MA; Prat I; Querol S; Garrido G; Matesanz R; Carreras E; Duarte RF
Bone Marrow Transplant; 2018 Jun; 53(6):741-748. PubMed ID: 29410548
[TBL] [Abstract][Full Text] [Related]
56. Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.
Myburgh R; Ivic S; Pepper MS; Gers-Huber G; Li D; Audigé A; Rochat MA; Jaquet V; Regenass S; Manz MG; Salmon P; Krause KH; Speck RF
J Virol; 2015 Jul; 89(13):6761-72. PubMed ID: 25903342
[TBL] [Abstract][Full Text] [Related]
57. Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases.
Li L; Krymskaya L; Wang J; Henley J; Rao A; Cao LF; Tran CA; Torres-Coronado M; Gardner A; Gonzalez N; Kim K; Liu PQ; Hofer U; Lopez E; Gregory PD; Liu Q; Holmes MC; Cannon PM; Zaia JA; DiGiusto DL
Mol Ther; 2013 Jun; 21(6):1259-69. PubMed ID: 23587921
[TBL] [Abstract][Full Text] [Related]
58. Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.
Cohen OJ; Vaccarezza M; Lam GK; Baird BF; Wildt K; Murphy PM; Zimmerman PA; Nutman TB; Fox CH; Hoover S; Adelsberger J; Baseler M; Arthos J; Davey RT; Dewar RL; Metcalf J; Schwartzentruber DJ; Orenstein JM; Buchbinder S; Saah AJ; Detels R; Phair J; Rinaldo C; Margolick JB; Pantaleo G; Fauci AS
J Clin Invest; 1997 Sep; 100(6):1581-9. PubMed ID: 9294127
[TBL] [Abstract][Full Text] [Related]
59. Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5Δ32/Δ32 Donor Cells.
Huyveneers LEP; Bruns A; Stam A; Ellerbroek P; de Jong D; Nagy NA; Gumbs SBH; Tesselaar K; Bosman K; Salgado M; Hütter G; Brosens LAA; Kwon M; Diez Martin J; van der Meer JTM; de Kort TM; Sáez-Cirión A; Schulze Zur Wiesch J; Boelens JJ; Martinez-Picado J; Kuball JHE; Wensing AMJ; Nijhuis M;
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146874
[TBL] [Abstract][Full Text] [Related]
60. Prognostic value of a CCR5 defective allele in pediatric HIV-1 infection.
Romiti ML; Colognesi C; Cancrini C; Mas A; Berrino M; Salvatori F; Orlandi P; Jansson M; Palomba E; Plebani A; Bertran JM; Hernandez M; de Martino M; Amoroso A; Tovo PA; Rossi P; Espanol T; Scarlatti G
Mol Med; 2000 Jan; 6(1):28-36. PubMed ID: 10803406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
